George Putnam
The Turnaround Letter
Geoffrey Seiler
Bullmarket.com
Chuck Carlson
The DRIP Investor
Nicholas Vardy
Bull Market Alert

Easy gains with EZChip (EZCH)?


Bookmark and Share

 "My top stock for 2009 is EZChip (NASDAQ: EZCH)," says technology expert Paul McWilliams in Next Inning. Indeed, the leading advisor believes the chip stock could double in 2009.

"I came as close as I've ever come to 'pounding the table' when suggesting that Next Inning readers buy EZCH when the stock was trading in the $6's and continue to believe the stock provides a very attractive balance between risk and potentially high rewards from its current price in the mid-$11's.

Advertisement
Banner

"EZCH has captured designs at tier one and tier two networking companies with its innovative and highly pipelined network processor (NPU) and I believe is set to do the same with its soon-to-be- released NPU aimed at the access markets.

"These design wins have been several years in the making and the products, which include the wildly successful Juniper (JNPR) MX series of routers and are just now building momentum.

"In addition to being used in the JNPR MX series, which is the fastest growing product line in the history of the company, I believe Cisco has designed in the new EZCH NP-3C in its highly promoted ASR9000.

"EZCH flipped from an operating loss to an operating profit in Q3 2007 and has since grown its pro forma operating profit margin to 22.7%.

"My forecast suggests we should expect a pro forma EPS in 2009 that is comfortably above $1.00 per fully diluted share and that the company may end 2009 reporting a gross profit margin approaching 80%.

"With what I view as a solid potential to grow revenues and profits for years to come and $1.90 in net cash per outstanding share, I think EZCH has the potential to double during the next twelve months."


News Flash

Goldcorp: 'My favorite major'
by Curtis Hesler, editor Professional Timing Service

The secular bull in gold and the commodity sector is not over. However, it is not at the ground floor any longer either; as such, stock selection must be more carefully considered.


Read more...

 

Money manager's small cap buys
by Jim Oberweis Jr., editor The Oberweis Report

Small-cap growth stock valuations are cheap, and like most things in life, economies are cyclical, even if this is a long and painful one. For the rare, brave contrarian with a reasonably long time horizon, that spells opportunity.


Read more...


   

Opportunities in homebuilding?
by Bernie Schaeffer, editor Schaeffer's Investment Research

Based on our "expectational analysis" strategy -- which  combines fundamental, sentiment and technical metrics -- I initiated long positions in two homebuilding stocks: Lennar Corporation (LEN) and Toll Brothers (TOL).


Read more...

 

Cliffs Natural: A DRIP favorite
by Vita Nelson, editor MoneyPaper

Our latest featured dividend reinvestment stock is Cliffs Natural Resources (CLF). Founded in 1847, the former Cleveland-Cliffs is the largest producer of iron ore pellets in North America.


Read more...

 

S&P's trio of info tech ETFS
by Dylan Cathers, S&P Capital IQ Equity Analyst, S&P The Outlook

Information technology is one of four sectors that S&P Capital IQ’s Sector Strategy Group currently recommends investors overweight in their portfolios.


Read more...

 

Crescent Point: Bakken bet
by Brian Hicks, editor Wealth Advisory

Master Limited Partnerships (MLPs) are unique investments that combine the tax benefits of a limited partnership (LP) with the liquidity of common stock.


Read more...

 

Natural gas: A bottom?
by Jason Cimpl, editor Daily Profit

Natural gas has collapsed for the past four years and has been on a gradual decline for almost a decade. Prices topped near $16 in 2005 and then declined to $2. So did natural gas just bottom?


Read more...

 

FBR Focus bests 99% of peers
by Walter Frank, editor MoneyLetter

Funds that invest in a relatively few stocks or sectors are less diversified than broadly invested funds and their volatility can be much higher. But the team at FBR Focus (FBRVX) seems to be getting it right.


Read more...

 

Celgene: Catalysts ahead
by John McCamant, editor Medical Technology Stock Letter

Celgene (CELG) recently kicked off the 2012 JP Morgan Healthcare conference by pre-announcing 4Q11 results and providing 2012 guidance.


Read more...

 

Water, water
by Richard Band, editor Profitable Investing

In the current environment, investors should focus any new stock purchases on companies with recession-resistant franchises and generous dividends -- such as water utilities.


Read more...